Novartis India

Novartis India Reimagining medicine in India since 1947. Our people make us a Great Place to Work 2026®, & we are recognised among Asia’s Best Workplaces 2025™.

See our community guidelines: https://go.novartis.social/3Nbo
See our privacy policy: https://bit.ly/4m9iGug

Every role and every function at Novartis supports one shared goal: bringing medicines to patients to improve and extend...
08/05/2026

Every role and every function at Novartis supports one shared goal: bringing medicines to patients to improve and extend lives.

This message came through powerfully during Mukul Mehta’s (CFO, Novartis) visit to NOCC Hyderabad this week, where it was a pleasure to welcome him, learn from his perspectives, and engage in thoughtful conversations across teams.

Through a candid townhall, a fireside chat, and interactions with colleagues and leaders, Mukul shared insights on what is driving Novartis’ growth today and what will shape it in the future. His reflections were grounded, forward‑looking, and deeply connected to our purpose.

What stood out was his emphasis on using AI thoughtfully to strengthen decision‑making and amplify impact. AI, he noted, should augment our thinking while keeping our fundamentals strong, all with one clear intent: accelerating impact for patients.

Grateful for the time, the conversations, and the inspiration!

24/04/2026

True innovation takes shape when academia and industry come together to solve real‑world challenges.

𝗡𝗘𝗦𝗧 𝟮.𝟬 (𝗡𝘂𝗿𝘁𝘂𝗿𝗶𝗻𝗴 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲, 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗧𝗮𝗹𝗲𝗻𝘁), an initiative by the Novartis Development India Hub, built on the foundation of its first edition, evolved into a more partnership‑driven platform rooted in collaboration and co‑creation with academic institutions.

Over several months, the initiative engaged students and faculty across India, starting with campus interactions where leaders from the Novartis Development India Hub connected directly with young talent. These engagements enabled problem‑solving at the intersection of academic thinking and real‑world healthcare needs.

The scale was significant: 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗼𝘃𝗲𝗿 𝟳,𝟬𝟬𝟬 𝗰𝗼𝗹𝗹𝗲𝗴𝗲𝘀 𝗮𝗻𝗱 𝟯𝟯,𝟬𝟬𝟬+ 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝟮𝟰,𝟬𝟬𝟬+ 𝘁𝗲𝗮𝗺𝘀, but the impact went far beyond numbers. Supported by faculty mentors and Novartis experts, students developed solutions grounded in responsible innovation and practical relevance.

In the Grand Finale held over two days at the Novartis Corporate Center in Hyderabad, 𝘀𝗶𝘅 𝘁𝗲𝗮𝗺𝘀 - 𝘁𝗵𝗿𝗲𝗲 𝘄𝗶𝗻𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝘁𝗵𝗿𝗲𝗲 𝗿𝘂𝗻𝗻𝗲𝗿𝘀 𝘂𝗽 𝘄𝗲𝗿𝗲 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘀𝗲𝗱 for applying AI, advanced analytics, and digital technologies to make processes across clinical trials, patient safety, and technical R&D more intelligent and efficient. The journey reaffirmed our belief in India’s next generation of innovators, reflected in the depth of talent and quality of ideas on display.

At Novartis, initiatives like NEST reflect our long‑term commitment to 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗮𝗻𝗱 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆, strengthening talent ecosystems, and nurturing a 𝗯𝗼𝗹𝗱, 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁 𝘄𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 ready to shape the future of healthcare innovation.

Tune into the NEST 2.0 special on CNBC-TV18 airing at 5pm IST this Saturday, with a repeat at 3:30pm IST this Sunday.

From a 20 member pilot in 2001 to a 9,000 strong global hub today. The journey of Novartis Corporate Center (NOCC) in In...
20/04/2026

From a 20 member pilot in 2001 to a 9,000 strong global hub today.
The journey of Novartis Corporate Center (NOCC) in India is built on belief, capability and trust.

Lira Parvez’s story captures the spirit of those early days and the foundation that helped shape one of Novartis’ most mature global centres.

Here’s to 25 years of reimagining medicine in India for the world.

Strengthening India’s science ecosystem, together.A strong pharmaceutical Research and Development (R&D) ecosystem does ...
16/04/2026

Strengthening India’s science ecosystem, together.
A strong pharmaceutical Research and Development (R&D) ecosystem does not grow in isolation. It is shaped through steady collaboration across education, research, and the translation of academic research into real world impact.

We are pleased to share that we have signed the Faculty Pioneer Grant with the National Institutes of Pharmaceutical Education and Research. Aimed at advancing R&D excellence across the NIPER network, the grant has been awarded to NIPER SAS Nagar.

We would like to thank all faculty members across the NIPERs who participated in the process. A special thank you to Shri Manoj Joshi (IAS), Secretary, Department of Pharmaceuticals for his presence during the signing. Through partnerships like these, we continue working towards a future where research translates into meaningful outcomes for patients across India and beyond.

India stands among the world’s leading pharmaceutical producers, powered by strong science, talent, and scale. The oppor...
14/04/2026

India stands among the world’s leading pharmaceutical producers, powered by strong science, talent, and scale. The opportunity now is to accelerate innovation and collaboration to deliver meaningful breakthroughs for patients everywhere.

These priorities were reinforced at FICCI India Pharma 2026, where Hon’ble Union Health Minister J.P.Nadda spoke about India’s ambition to play a leading global role in pharmaceutical innovation, alongside the government’s focus on Bio Pharma Shakti to strengthen research and development and build a future ready life sciences ecosystem.

Reflecting this shared vision, Novartis India was proud to champion a value driven, patient first approach to innovation through a dedicated booth and senior leadership engagement. Amitabh Dube contributed to the dialogue through a panel discussion, sharing perspectives on the importance of an enabling policy and ecosystem environment to advance innovation, strengthen research, and improve patient access over the long term.

As we move forward, we remain committed to reimagining medicine by asking the harder questions, fostering meaningful collaboration, and keeping patients firmly at the heart of everything we do.

Federation of Indian Chambers of Commerce & Industry (FICCI) Department of Pharmaceuticals Ministry of Health and Family Welfare, Government of India

The most profound breakthroughs happen at the intersection of expertise and purpose.On  , Novartis continues to advance ...
07/04/2026

The most profound breakthroughs happen at the intersection of expertise and purpose.

On , Novartis continues to advance research by bringing life-changing medical breakthroughs closer to patients. Through active clinical trials and collaborative innovation, efforts are focused on strengthening the future of healthcare in India.

From discovery through development, the goal remains clear: to address complex diseases and expand what is possible for patients. When science is guided by intent, it creates the possibility of longer lives, better quality of care, and healthier futures for people and communities.

Vinay Mahajan’s remarkable journey from junior programmer to senior director, statistical programming, reflects the spir...
25/03/2026

Vinay Mahajan’s remarkable journey from junior programmer to senior director, statistical programming, reflects the spirit of growth and opportunity at NOCC.

His career is defined by curiosity, integrity, resilience, and a steadfast commitment to applying statistical insights that support better decisions in medicine. We are proud to have leaders like Vinay, whose expertise continues to drive our mission of every day.

Cardiovascular disease is one of the leading causes of death in India. Although this very common disease can affect fami...
24/03/2026

Cardiovascular disease is one of the leading causes of death in India. Although this very common disease can affect families, impact communities and disrupt workplaces, some powerful risk factors often go unnoticed.

Lipoprotein(a) or Lp(a), is one such silent threat. While other common markers can be controlled with lifestyle changes and show symptoms, Lp(a) is inherited and completely asymptomatic. A seemingly healthy individual may unknowingly harbour this risk. This highlights the importance of awareness.

On this , let us prioritise our heart health and encourage our loved ones to do the same.

Get yourself and your family tested for Lp(a) as soon as possible. It enables you to more precisely assess your cardiovascular risk and, if necessary, take prompt action. Because prevention doesn’t just save lives — it safeguards futures.

At , reimagining medicine also means enabling greater awareness and informed decision-making. Through continued engagement and scientific collaboration, we remain committed to improving heart health across the country.

22/03/2026

𝗪𝗮𝘁𝗲𝗿 𝘀𝗲𝗰𝘂𝗿𝗶𝘁𝘆 𝗹𝗲𝗮𝗱𝘀 𝘁𝗼 𝗮 𝗯𝗲𝘁𝘁𝗲𝗿 𝗹𝗶𝗳𝗲 𝗮𝗻𝗱 𝗮 𝗯𝗿𝗶𝗴𝗵𝘁𝗲𝗿 𝗳𝘂𝘁𝘂𝗿𝗲.

India is one of the most water-stressed regions in the world, with millions across the country lacking reliable access to water. Recognising the link between water access, health and livelihoods, Novartis partnered with the non-profit National Agro Foundation to launch an integrated watershed development project in five villages near Hyderabad to help address water scarcity in Telangana.

The initiative is already creating meaningful impact at the community level. More than 13,000 trees have been planted, crop yields have improved by 25%, and community incomes have increased by 10%. Beyond water conservation, the project takes a holistic approach to development by supporting livelihoods, sanitation, education and clean energy. Women-led self-help groups are creating new businesses and economic opportunities, while improved water availability is strengthening agricultural productivity and overall community well-being.

These outcomes are enabled through interventions such as creating water bodies, constructing check dams, rejuvenating ponds and improving rainwater harvesting. The first phase has already impacted more than 20,000 lives and created over 344,000 cubic metres of water storage capacity.

As the project expands to new communities, it continues to support Novartis’ broader commitment to responsible water stewardship and its goal of achieving water neutrality by 2030.

Science moves forward through curiosity, innovation, and a drive to discover what’s next. This spirit was at the heart o...
19/03/2026

Science moves forward through curiosity, innovation, and a drive to discover what’s next.

This spirit was at the heart of our National Science Day celebrations at the Genome Valley Site in February. We honoured Dr. C. V. Raman’s discovery of the Raman Effect and reflected on how science continues to shape the future of healthcare.

Throughout the week, teams came together for a range of engaging activities. We hosted an insightful guest lecture by Prof. C. Malla Reddy from Indian Institute of Technology, Hyderabad, who connected core scientific principles with real‑world pharmaceutical development.

Associates also took part in quizzes, poster presentations, a science carnival and flash talks by our internal experts.

As we celebrated the spirit of discovery, the week reminded us that scientific curiosity continues to power how we work to extend and improve people’s lives every day.

Address

Mumbai

Alerts

Be the first to know and let us send you an email when Novartis India posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Novartis India:

Share